# Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-dulaglutide-in-the-treatment-of-type-2-diabetes-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johan Jendle,George Grunberger,Thomas Blevins,Francesco Giorgino,Ryan T. Hietpas,Fady T. Botros |
| Citations | 155 |
| DOI | 10.1002/dmrr.2810 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dmrr.2810 |
| OpenAlex ID | https://openalex.org/W2414005931 |
| PMID | 27102969 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Fady T. Botros](https://scholariq.org/researchers/fady-t-botros/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.